Filamentous hemagglutinin is a surfaceassociated adherence protein of Bordetella pertussis, which is a component of some new acellular pertussis vaccines. The
Filamentous hemagglutinin (FHA), a basic surface-associated protein produced by Bordetella pertussis, has received attention as a putative adhesin, virulence determinant, and component of some new acellular pertussis vaccines (1) . FHA is poorly characterized; it migrates as a heterogeneous collection of polypeptide species on SDS/PAGE, ranging from approximately 60 to 220 kDa. It is likely that the smaller protein bands represent degradation products of a dominant 220-kDa species (2) . Hemagglutinating activity for erythrocytes, including those of humans, is associated with the largest of these polypeptide species. FHA is a filamentous structure with dimensions of 2 nm x 40-100 nm (3, 4) , quite distinct from B. pertussis fimbriae (4, 5) .
Two biological properties attributed to filamentous hemagglutinin relate to its potential role in pertussis pathogenesis and the accompanying host immune response. B. pertussis adheres specifically to human ciliated respiratory epithelial cells during natural infection. In vitro adhesion assays with a variety of ciliated and nonciliated eukaryotic cells suggest that FHA is the most important adhesin mediating this bacterial-host cell interaction (6) (7) (8) . Secondly, FHA stimulates an immune response in humans after clinical disease (9, 10) and acts as an immunoprotective antigen in a mouse model system (11) . Although less effective than pertussis toxin when used alone, FHA and pertussis toxin together demonstrate a synergistic immunoprotective effect (12, 13) .
Three reports describe the cloning of the FHA structural gene (14) or a portion thereof (15, 16) . Work in our laboratory (17) , however, has shown that the beginning of the FHA structural gene,JflaB, lies at a position -3 or 5 kilobases (kb) to the left of the regions contained within each of the two reported clones for which a restriction map or nucleotide sequence data are available (14, 16) . Two genetic loci, linked tofhaB, are involved in FHA expression. B. pertussis strains BP353 and BP354 have TnS insertion mutations in a locus, fhaA, which is adjacent to the FHA structural gene. These two strains have been widely used as FHA-controls in various biological studies but actually produce low levels of intact FHA (8, 14) . A third FHA genetic locus, flhaC, also involved in FHA expression is adjacent toflhaA (see Fig. 1 ).
We report here the finding of an open reading frame (ORF), at least 9783 base pairs (bp) long, which corresponds to fhaB. 11 The size of the ORF and the finding of a predicted polypeptide processing site within the predicted amino acid sequence suggest a role for proteolytic processing in the synthesis of mature FHA. An Arg-Gly-Asp (RGD) tripeptide site occurs within the deduced peptide sequence that may serve as a eukaryotic cell recognition site and play a role in the function of this protein as an adhesin. Finally, using cultured Chinese hamster ovary (CHO) cells, rabbit ciliated respiratory epithelial cells, and a series of new B. pertussis mutants we demonstrate an essential role for FHA in mediating bacterial adherence to eukaryotic cells.
MATERIALS AND METHODS
Bacterial Strains and Plasmids. B. pertussis strain BP536 is a streptomycin-resistant mutant of the virulent phase I parental strain BP338 (18) . BP537 is an avirulent phase variant of BP536. The isolation of the TnS mutant BP353 has been described (18) ; the transposon insertion site has been mapped more recently (17) . BP338TnS-25 carries a TnS insertion mutation within the 2.4-kb BamHI segment ofJhaB (17) . BP338TnS-16 has a similar mutation -8-9 kilobases (kb) downstream from the EcoRI site at the 5' end ofIhaB (17) . BP-TOX6 (ptxA6) is a derivative of BP536 with a deletion of the pertussis toxin operon and the substitution of a kanamycin-resistance cassette at that location. BP-B52 (fim2B52, fim3::Km) (gift from F. Mooi, RIVM, Bilthoven, The Netherlands) is a BP536 derivative with separate insertion mutations that inactivate thefim2 andfim3 genes. Escherichia coli strains JM101 and SM10 have been described elsewhere (19, 20) . Cosmid pUW21-26 is a derivative of pHC79 (21) with an -45-kb insert containing the cloned vir and fha loci from BP338 (17) . The construction of plasmid vector pRTP1 has been described (22) .
Cloning offiaB and Construction offltaB Deletion Mutants. The presumed FHA structural gene, JhaB, was cloned on a 10-kb EcoRI fragment from cosmid pUW21-26 into the vector pRTP1, creating the recombinant plasmid pDR1 (see Fig. 1 ). An in-frame partial deletion of JhaB was constructed by re-ligating a pool of BamHI partial digests of pDR1. Plasmids were screened for the loss of an internal 2.4-kb BamHI Proc. Natl. Acad. Sci. USA 86 (1989) fragment. The resultant plasmid was designated pDR101 (see Fig. 1 ).
Bacterial Coijugations and Allelic Exchange. The method for conjugative transfer of pRTP1 derivatives from E. coli to B. pertussis has been described elsewhere (22 Hemagglutination. The ability of B. pertussis strains to agglutinate sheep erythrocytes was assayed as described previously (14) .
Western (Immunologic) Blots. SDS/PAGE was performed with a 10% separating gel and 20 A.l of boiled (OD600 = 10) B.
pertussis cell suspension in sample buffer. Transfer of protein to nitrocellulose membrane followed the procedure of Towbin et al. (27) . FHA was immunologically detected by use of a 1:1000 dilution of a mixture (1-54, 1-199, 31E2, 22F10, and 68A6) of monoclonal anti-FHA antibodies (gift from F. Mooi), followed by incubation with a 1:250 dilution of horseradish peroxidase-conjugated goat anti-mouse antisera.
Fim2 and Fim3 production were detected using monoclonal antibodies (21E7 and 8E5) specific for these two proteins, respectively (gift from F. Mooi). Southern Hybridization. B. pertussis chromosomal DNA was isolated, digested with restriction endonucleases, and separated by agarose gel electrophoresis according to standard techniques (28) . Transfer of fragments to nitrocellulose was accomplished by the method of Smith and Summers (29) .
In Vitro Bacterial Adherence to CHO Cells. B. pertussis strains were grown on Bordet-Gengou agar (Difco) containing 15% sheep blood for 2 days and washed twice in phosphate-buffered saline (PBS). Twenty microliters of bacterial suspension (OD6w studied in duplicate, and all experiments were repeated at least twice. Bacteria adherent to 10-25 CHO cells were counted visually, and the means ± SD were determined for each strain. Joint 95% confidence intervals were computed based on central-limit-theorem approximations and Bonferoni techniques (30) .
In Vitro Bacterial Adherence to Ciliated Respiratory Cells. B. pertussis adherence to rabbit ciliated respiratory epithelial cells was measured using a published method (6) . In some cases bacteria were pretreated with 50 pug of FHA or 10 The internal 2.4-kb BamHI fragment of flaB (see Fig. 1) was deleted as described, and the mutation was returned to the BP536 chromosome, yielding strain BP101 (JhaBA101). The structure of the resultantflzaB mutant locus in this strain was confirmed by Southern blot analysis. The largest FHA cross-reactive polypeptide produced by BP101 measured =150 kDa, as determined by Western blot technique (data not shown). BP101 cells had no hemagglutinating activity, indicating that the truncated FHA product lacked this biological function. On the other hand, BP338TnS-16 produced fulllength 220-kDa product on FHA immunoblots. These data confirmed that the structural gene for FHA is contained on the 10-kb EcoRI insert of pDR1 (see Fig. 1 Fig.  3 .
The relative G+C content of the 9783-bp sequence is 67.5%. Examination of this nucleotide sequence for transcriptional start signals indicates regions TTGACTA and TATAAAT, corresponding closely to the E. coli -35 and -10 consensus sequences, located upstream of the first ATG codon (see Fig. 2 ). The spacing between these regions is 21 bp, similar to the 22-bp spacing of the B. pertussis ptx promoter, another positively regulated locus. There is no obvious ribosomal binding site appropriately placed for the three possible translational start codons. Two different inverted DNA repeats with stem lengths of 15 and 12 bp, respectively, overlap each of the first two in-frame ATG codons (see Fig. 2 ). Further analysis of the nucleotide sequence reveals a region of alternating repeats of the pattern ABABA, where A and B are 50 and 60 bp long, respectively. This region is located between 1468 and 1746 bp from the upstream EcoRI site. Repeats of the same pattern are found in the predicted amino acid sequence corresponding to this region.
Predicted Amino Acid Sequence. The predicted amino acid sequence of the 9783-bp FHA ORF from its beginning to the downstream EcoRI site is 3261 residues long, with a calculated molecular size of 332 kDa. This size is substantially larger than published measured values for the largest native mature FHA polypeptide. The composition of this sequence is alanine and glycine rich (28.1%) and is nearly identical to a previously published chemical analysis of FHA amino acid composition (34) .
The concentration of charged residues in the FHA polypeptide chain is highest between amino acid positions 2000 and 2700. (Amino acid positions are based upon translation from the first ATG codon 253 bp from the upstream EcoRI site.) Hydrophobicity is highest in the N-terminal 1000 residues and again between residues 1800-2000 and 2400-2500. There is a highly predicted transmembrane helix located between residues 52 and 69. Searches for homology One interesting feature of the predicted amino acid polypeptide is the sequence Arg-Arg-Ala-Arg-Arg (RRARR) located at position 1069. This highly arginine-rich sequence is a likely site for trypsin-like proteolytic cleavage (35) . If the mature 220-kDa FHA product were to be encoded at the beginning of the ORF, one would predict that cleavage at RRARR would result in polypeptides of 104 kDa and 116 kDa in size. Polypeptides of these two sizes are seen on FHA Western immunoblots (data not shown). Analysis of these two derivative FHA peptide sequences demonstrates several differences in chemical properties: the N terminal 104-kDa portion is highly basic with a positive hydropathy score and a pI of 10.26, whereas the C-terminal 116-kDa portion is a negatively charged acidic polypeptide that has a more hydrophilic composition and a pI of 6.42. The predicted pI of a 220 kDa polypeptide, comprising the first 2165 residues of the ORF, is 9.41; the measured pI of bioactive FHA is 8.1 (5).
Cell Recognition Site. Located at amino acid position 1097 and again at position 2599 is the tripeptide sequence arginineglycine-aspartic acid (RGD). This sequence is known as a "cell recognition site" for the interaction of fibronectin and other eukaryotic extracellular matrix proteins with the integrin receptor superfamily (36, 37) . Secondary-structure analysis of the polypeptide sequence adjacent to these two FHA RGD sites reveals that the first of these is highly predicted to be surface exposed, hydrophilic, and antigenic. Comparison of the FHA peptide sequence adjacent to this RGD site with the sequence surrounding the RGD site in fibronectin shows identity at seven of the nine positions (see Fig. 4 ).
In Vitro Bacterial Adherence to CHO Cells. We evaluated the role of several virulence factors in mediating adherence of B. pertussis to CHO cells. BP537, a Vir-negative control strain, bound to CHO cells at a level 0.7% that of BP536, the Vir' positive control and wild-type parental strain (see Table   1 ). BP101, the IhaB deletion mutant, adhered at 3.0% the level of BP536. BP338TnS-16 bound to CHO cells as well as BP536 (data not shown). In comparison, isogenic strains deficient in either fimbrial protein or pertussis toxin production showed no significant differences in levels of adherence when compared to the wild-type strain.
In Vitro Bacterial Adherence to Ciliated Respiratory Cells. The adherence of the B. pertussis strains to rabbit ciliated (38) , the adenylate cyclase gene (cya) (39) , and the serotype 2 fimbrial subunit gene (fim2) (40) shows no similarity with postulated transcriptional and translational control signals in these other sequenced B. pertussis genes, aside from the ptx promoter spacing discussed earlier. As is the case with cya (39) the sequence 5' to the FHA ORF is significantly less G+C-rich (51%) than the ORF itself (67.5%).
Although we have not yet identified the exact transcriptional start site forflaB, other work in our laboratory, using a transcriptional lacZ fusion to the 5' EcoRI-BamHI fragment offlzaB, suggests a vir-dependent promoter sequence is located within the first 2840 bp of the JhaB EcoRI fragment (J. F. Miller, D.A.R., and S.F., unpublished data). B.
pertussis preferred-codon-usage analysis implicates the first ATG of the FHA ORF as the translational start site; in addition, translation from the first ATG generates a strongly predicted transmembrane segment that begins within the 58 residues before the third ATG. There is no typical signal sequence located at any ofthe three 5' ATG codons, although this protein is excreted.
FHA Structure and Processing. The fhaB sequence is unusually long. While molecular weight measurements of large, self-aggregating proteins can be misleading, the predicted weight of the intact polypeptide encoded by the entire ORF is substantially larger than any published measurements of functional FHA. Amino acid sequencing of a random peptide fragment from purified 220-kDa FHA polypeptide has revealed the sequence Ile-Gly-Leu-Glu-Gly, which is found at amino acid position 800 (J. Cowell, personal communication). This finding and the analysis of BP338Tn5-16 suggest that the mature 220-kDa FHA polypeptide species is encoded by the early portion of the FHA ORF. The analysis of BP101 is consistent with this hypothesis. Implicit is the assumption that the 220-kDa species is cleaved from a precursor polypeptide at a processing site -2100-2200 residues from the first ATG.
Further suggestion of proteolytic processing is found in the predicted amino acid sequence. A prominent arginine-rich site, Arg-Arg-Ala-Arg-Arg (RRARR), located at amino acid position 1069, closely resembles the site of diphtheria toxin fragment A-chain proteolytic nicking (35) ; this suggests that an FHA polypeptide may be subject to trypsin-like cleavage at this site. The finding of the 220-kDa polypeptide sequence Ile-Gly-Leu-Glu-Gly upstream of the putative ArgArg-Ala-Arg-Arg processing site argues that it is the 220-kDa species that is cleaved at this site. N-terminal amino acid sequence determination of several of the SDS/PAGE FHA peptide bands confirms that cleavage, in fact, occurs at the Arg-Arg-Ala-Arg-Arg site (Carime Capiaux, personal communication). Other less dramatic arginine-rich sites in the FHA-deduced amino acid sequence may be secondary proteolytic cleavage sites, giving rise to the numerous lower molecular mass bands seen after storage of purified 220-kDa FHA polypeptide. This may explain previous reports that FHA is prone to proteolytic degradation (2, 5) .
FHA as an Adhesin. Previous reports have suggested that FHA plays an important role in mediating B. pertussis adherence to cultured eukaryotic cells (6) (7) (8) . These studies have been limited by their reliance solely on the inhibitory effects of anti-FHA antibodies, the enhancing effects of exogenous FHA, and the use of BP353, a strain that produces small amounts of functional FHA (8, 14) and is deficient in fimbrial subunit 2 and 3 production (6). Our findings, based upon the use of strains each missing a putative adherence factor, strongly argue for a primary role for FHA in eukaryotic cell attachment. BP101 carries a defined in-frame deletion within ffhaB, without apparent disruption of adjacent, Fibronectin is the prototype protein for which RGD mediates cell interactions with integrin receptors (36, 37) . A number of other adhesive proteins, including the eukaryotic extracellular matrix proteins laminin and collagen, contain RGD sequences, although in some cases the tripeptide has not been definitively associated with a biological function. There is circumstantial evidence that the first RGD site in the FHA sequence is involved in adherence: (i) the first, but not the second, RGD is predicted to be surface-exposed; (ii) amino acids adjacent to the first RGD are similar to the fibronectin RGD site; and (iii) deletion of a large portion of fhaB that includes the first RGD causes loss of adherence activity. Adherence activity by an FHA RGD site does not exclude similar roles for additional protein domains. In the case of fibronectin, a second functional domain is equally important as, and acts synergistically with, the RGD site in interactions with cultured fibroblasts (43) .
It is interesting to speculate that B. pertussis may share a common eukaryotic mechanism for cell-cell interactions. By producing filamentous hemagglutinin under certain conditions in the human upper respiratory tract this bacterium may be creating its own extracellular matrix in its attempts to colonize and multiply. As a side effect, it may inadvertently provide other bacterial respiratory pathogens an adhesin for secondary colonization (41) .
